• DC

    Save the date!

    The Washington D.C. Patient Education Symposium

    When:
    Thursday, March 19, 2015

    Click on this slide for more information.

  • women-mpn-slider

    Women and MPNs

    Meet the women in the trenches of MPNs. A new profile of MPNs is emerging, as younger patients are being diagnosed and new issues are being recognized by the MPN medical community who see women experiencing additional challenges who have myelofibrosis, essential thrombocythemia, and polycythemia vera.

  • 100524-N-4205W-002

    Are You a Vietnam Veteran?

    Do You Have Myelofibrosis (MF), Polycythemia Vera (PV) or Essential Thrombocythemia (ET)?

    Were you exposed to Agent Orange?

    If so please contact us at:
    517.899.6889 or email Ann Brazeau at abrazeau@mpnadvocacy.com

    For additional information and to read Vietnam Veteran Barry's story click on the title above.

  • events-page-1

    Two Patients Share Their MPN Stories

    Kazumi U. shares her story about living with ET and post-ET Myelofibrosis.
    "I was diagnosed as having essential thrombocythemia in the summer of 1992 when I was visiting Japan from the U.S. to care for my ailing mother."

    Marilyn C. was diagnosed with Polycythemia Vera 13 years ago. She wanted to share her journey with other patients, families and caregiverS.
    "My MPN journey began in March 2001. One night I awoke with a burning inside my
    chest. The next day I went to my doctor..."

  • 8266471202_63a8f743a9_b

    Need Help Paying for MPN Treatment?

    More than one-third of people with chronic diseases, including MPNs, have health insurance but still cannot afford the co-payments for specialty medications needed to manage their diseases. That leaves numerous patients with treatments in sight but out of reach. Most pharmaceutical companies have “Patient Assistance Programs” to help make the cost of prescription medications affordable to the patient. Learn more about your options.

Educational Events

Ruben MesaPictured at left  is Dr. Ruben Mesa, Mayo Clinic, our Scientific Advisor.

Dr. Mesa was one of the featured speakers at the San Mateo Patient Education Symposium held on May 22, 2014. Click here for Webcasts of all speakers at this event.

  •  Click on this link for slides from the featured speakers of the Tampa Bay Area Symposium held on  April 3, 2014.
  • You can watch video of all of the featured speakers at our Washington D.C Symposium held on January 8, 2014 .
  • Information from our featured speakers at our recent  Cleveland, Ohio Symposium will be available soon.

 

Click on the “Learn More” link below for a complete Calendar of Events for 2015, and 2016 Learn More

 

Patient & Caregiver Support

stock1Join with other patients to learn more about your disease and treatment options through an in-person or online support group. Many major cities throughout the United States and internationally host regular meetings. Contact Ann Brazeau if you are interested in establishing a new Support Group for your area : 517.899.6889  abrazeau@mpnadvocacy.com Learn More

Science Advisor: Ruben Mesa

Our scientific advisor is Dr. Ruben Mesa of the Mayo Clinic. Read his latest update: MPN Highlights from the American Society of Hematology

Free Patient Info Pack

Give us your address and we’ll send you a free informational package in the mail. Your contact information will be kept strictly confidential. Sign Up Now

FAQs

What is a myeloproliferative neoplasm? MPNs are a group of rare blood cancers that overproduce blood cells in the bone marrow, and are caused by genetic mutations in the blood stem cells:

  • Myelofibrosis is a rare bone marrow cancer. Bone marrow cells that produce blood cells develop and function abnormally resulting in fibrous scar tissue formation.
  • Polycythemia Vera is a disorder in which the bone marrow makes too many red blood cells. It may also result in the production of too many other types of blood cells – white blood cells and platelets.
  • Essential Thrombocythemia causes the body to produce too many blood platelets-thrombocytes. It can cause abnormal clotting or bleeding. The bone marrow makes too many platelet-forming cells or megakaryocytes, which release platelets into your blood.

Learn More